Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) shares crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 39.31 ($0.50) and traded as low as GBX 27.70 ($0.35). Cambridge Cognition shares last traded at GBX 27.70 ($0.35), with a volume of 69,024 shares.
Cambridge Cognition Price Performance
The firm has a 50-day moving average price of GBX 32.05 and a 200 day moving average price of GBX 39.31. The stock has a market capitalization of £11.62 million, a P/E ratio of -692.50 and a beta of 0.72. The company has a debt-to-equity ratio of 92.53, a quick ratio of 0.96 and a current ratio of 0.65.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
See Also
- Five stocks we like better than Cambridge Cognition
- Insider Buying Explained: What Investors Need to Know
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- What Are the U.K. Market Holidays? How to Invest and Trade
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Top Biotech Stocks: Exploring Innovation Opportunities
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.